http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010080927-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 1999-11-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20010080927-A |
| titleOfInvention | Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| abstract | The present invention relates to 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo [4.3.0] nonan-8-yl) -6-fluoro- of formula (I) To a limited crystal modifier of 1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, a process for its preparation and its use in pharmaceutical formulations:n n n n n n n n The crystal modifier according to the invention is characterized by its characteristic X-ray powder diffractogram and differential thermogram (see specification) of 8-cyano-1-cyclopropyl-7- (1S, 6S) Can be distinguished from other crystal modifiers of -2,8-diazabicyclo [4.3.0] nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid . |
| priorityDate | 1998-11-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 56 of 56.